Table 1 Cross-comparison between the four final (simplified) diagnostic labels obtained with implementation of Method-2016 and with Method-2021: “Astrocytoma”, “Oligodendroglioma”, “GBM” or “Unclassified”.

From: Updating TCGA glioma classification through integration of molecular data following the latest WHO guidelines

 

2021

Total

Astrocytoma

Oligodendroglioma

GBM

Unclassified

2016

Astrocytoma

208

5

41

18

272

Oligodendroglioma

41

164

12

10

227

GBM

33

2

441

119

595

Unclassified

0

0

12

4

16

 

Total

282

171

506

151

 
  1. For each class, the total of the updated samples is specified for both, Method 2016 (last column), and Method-2021 (last row). A total of 811 samples (diagonal cells, in bold) maintained consistent classification across both methods, while 134 cases (off-diagonal cells) have changed to a different class (unclassified cases not considered).
Back to article page